Carcinoid Tumor Clinical Trials Carcinoid Tumor RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
Conditions:   Carcinoid Tumor;   Metastatic Carcinoid Tumor;   Neuroendocrine NeoplasmInterventions:   Drug: Nintedanib;   Other: Pharmacological Study;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life AssessmentSponsors:   Roswell Park Cancer Institute;   National Cancer Institute (NCI)Not yet recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2015 Category: Research Source Type: clinical trials

Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors
Conditions:   Gastrinoma;   Glucagonoma;   Insulinoma;   Metastatic Gastrointestinal Carcinoid Tumor;   Pancreatic Polypeptide Tumor;   Pulmonary Carcinoid Tumor;   Recurrent Gastrointestinal Carcinoid Tumor;   Recurrent Islet Cell Carcinoma;   SomatostatinomaInterventions:   Drug: regorafenib;   Other: laboratory biomarker analysisSponsors:   University of Southern California;   National Cancer Institute (NCI)Not yet recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 7, 2014 Category: Research Source Type: clinical trials